PL413951A1 - Method for producing optically pure (+)-(R)-7-hydroxyflavanone - Google Patents

Method for producing optically pure (+)-(R)-7-hydroxyflavanone

Info

Publication number
PL413951A1
PL413951A1 PL413951A PL41395115A PL413951A1 PL 413951 A1 PL413951 A1 PL 413951A1 PL 413951 A PL413951 A PL 413951A PL 41395115 A PL41395115 A PL 41395115A PL 413951 A1 PL413951 A1 PL 413951A1
Authority
PL
Poland
Prior art keywords
hydroxyflavanone
optically pure
hours
organic solvent
water
Prior art date
Application number
PL413951A
Other languages
Polish (pl)
Other versions
PL233420B1 (en
Inventor
Edyta Kostrzewa-Susłow
Monika Dymarska
Tomasz Janeczko
Original Assignee
Uniwersytet Przyrodniczy we Wrocławiu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Przyrodniczy we Wrocławiu filed Critical Uniwersytet Przyrodniczy we Wrocławiu
Priority to PL41395115A priority Critical patent/PL233420B1/en
Publication of PL413951A1 publication Critical patent/PL413951A1/en
Publication of PL233420B1 publication Critical patent/PL233420B1/en

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Sposób wytwarzania (+)-(R)-7-hydroksyflawanonu o wzorze 2, polega na tym, że do podłoża odpowiedniego dla grzybów strzępkowych wprowadza się szczep Aspergillus niger SBJ, następnie po upływie co najmniej 48 godzin do hodowli wprowadza się substrat, którym jest (±)-octan 7-hydroksyflawanonu o wzorze 1, rozpuszczony w rozpuszczalniku organicznym mieszającym się z wodą, transformację prowadzi się przy ciągłym wstrząsaniu, co najwyżej 30 godzin, po czym produkt ekstrahuje się rozpuszczalnikiem organicznym niemieszającym się z wodą i oczyszcza chromatograficznie. Związek ten może znaleźć zastosowanie jako antyoksydant w przemyśle spożywczym oraz jako składnik preparatów farmaceutycznych i kosmetycznych.The method of producing (+) - (R) -7-hydroxyflavanone of the formula II consists in the introduction of Aspergillus niger SBJ strain into a medium suitable for filamentous fungi, then after at least 48 hours the substrate which is 7-hydroxyflavanone (±) -acetate 1, dissolved in a water-miscible organic solvent, transformation is carried out with continuous shaking, at most 30 hours, after which the product is extracted with a water-immiscible organic solvent and purified by chromatography. This compound can be used as an antioxidant in the food industry and as an ingredient in pharmaceutical and cosmetic preparations.

PL41395115A 2015-09-14 2015-09-14 Method for producing optically pure (+)-(R)-7-hydroxyflavanone PL233420B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL41395115A PL233420B1 (en) 2015-09-14 2015-09-14 Method for producing optically pure (+)-(R)-7-hydroxyflavanone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL41395115A PL233420B1 (en) 2015-09-14 2015-09-14 Method for producing optically pure (+)-(R)-7-hydroxyflavanone

Publications (2)

Publication Number Publication Date
PL413951A1 true PL413951A1 (en) 2017-03-27
PL233420B1 PL233420B1 (en) 2019-10-31

Family

ID=58360215

Family Applications (1)

Application Number Title Priority Date Filing Date
PL41395115A PL233420B1 (en) 2015-09-14 2015-09-14 Method for producing optically pure (+)-(R)-7-hydroxyflavanone

Country Status (1)

Country Link
PL (1) PL233420B1 (en)

Also Published As

Publication number Publication date
PL233420B1 (en) 2019-10-31

Similar Documents

Publication Publication Date Title
TN2016000268A1 (en) N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of shp2.
WO2017100305A8 (en) Composition of antibody construct-agonist conjugates and methods of use thereof
MX385720B (en) NEW HYDROXY ACID DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
AU2015205268A1 (en) Pyridylaminoacetic acid compound and polyoxyethylene castor oil-containing pharmaceutical composition
EA201890821A1 (en) NEW IMIDAZO DERIVATIVES [4,5-b] Pyridine as DYRK1 / CLK1 DUAL INHIBITORS
PH12020550125A1 (en) Crystalline forms of 3-substituted 1,2,4-oxadiazole
WO2018092042A3 (en) Solvent and method for extracting active compounds from plants and use of the solvent
WO2017019951A3 (en) Compositions amd methods of treating acne and photoaging
NZ713235A (en) Product and method for improving bioavailability of therapeutic compounds
PL417788A1 (en) 8-O-β-D-4"-methoxyglucopyranosyl-6-methylflavone and method for producing 8-O-β-D-4"-methoxyglucopyranosyl-6-methylflavone
PL413951A1 (en) Method for producing optically pure (+)-(R)-7-hydroxyflavanone
PL413949A1 (en) Method for producing optically pure (+)-(R)-7-hydroxyflavanone
PL413945A1 (en) Method for producing optically pure (+)-(R)-7-hydroxyflavanone
PL413955A1 (en) Method for producing optically pure (+)-(R)-7-hydroxyflavanone
PL413948A1 (en) Method for producing optically pure (+)-(R)-7-hydroxyflavanone
PL413947A1 (en) Method for producing optically pure (+)-(R)-7-hydroxyflavanone
PL413946A1 (en) Method for producing optically pure (+)-(R)-7-hydroxyflavanone
PL413939A1 (en) Method for producing optically pure (+)-(R)-7-hydroxyflavanone
PL413953A1 (en) Method for producing optically pure (+)-(R)-7-hydroxyflavanone
PL413950A1 (en) Method for producing optically pure (+)-(R)-7-hydroxyflavanone
PL417881A1 (en) Method for producing optically clean (+)-(R)-7-hydroxyflavanone
PL413954A1 (en) Method for producing optically pure (+)-(R)-7-hydroxyflavanone
WO2016069542A3 (en) Lactone compounds and methods of making and using same
EP4393320A3 (en) Method for obtaining betalain pigment composition from red beet plants
PL418557A1 (en) 4'-O-β-D-glucopyranosyl-4,2'-dihydroxy-3'-[3"-methylbutyl]-6'-methoxy-α,β-dihydrochalcone and method for obtaining 4'-O-β-D-glucopyranosyl-4,2'-dihydroxy-3'-[3"-methylbutyl]-6'-methoxy-α,β-dihydrochalcone